TABLE 2.
Comparison of Efficacy and Safety Outcomes, Pharmacokinetics, Pharmacodynamics, and Product Attributes After 1:1 Propensity Score Matching of Patients With Prior Bendamustine Use Within 6 Months or > 6 Months Versus No Use
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.